References
- BACKES, W. L. and CANADY, W. J., 1981, The interaction of hepatic cytochrome P-450 with organic solvents: the effect of organic solvents on apparent spectral binding constants for hydrocarbon substrates. Journal of Biological Chemistry, 256, 7213–7227.
- BECKETT, A. H. and NAVAS, G. E., 1978, Aromatic oxidation of some phenothiazines. Xenobiotica, 8, 721–736.
- BINDRA, A., GIRI, S. and KHULLER, G. K., 1995, Identification, localization and possible role of calmodulin like protein in phospholipid synthesis of Microsporum gypseum. Biochimica et Biophyska Ada, 1255, 118–122.
- BOLOGNESE, A., SCHERILLO, G. and SCHAFER, W., 1986, Reaction of o-aminophenol and p-benzoquinone in acetic acid. Journal of Heterocyclic Chemistry, 23, 1003–1006.
- BURKE, M. D. and MAYER, R. T., 1983, Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chemico -BiologicalInteractions, 45, 243–258.
- BURT, R. K. and THORGEIRSSON, S. S., 1988, Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. Journal of the National Cancer Institute, 80, 1383–1386.
- CINI, M., FARIELLO, R. G., BIANCHETTI, A. and Mort Ern, A., 1994, Studies on lipid peroxidation in the rat brain. Neurochemical Research, 19, 283–288.
- CLIN, B. and LEMANCEAU, B., 1969, Etude par resonance magnetique nucleaire des dibenzothiophene, phenoxathiine, dibenzoparathiazine et phenoxazine. Journal de Chimie Physique et de Physicochemie Biologique, 66, 1327–1329.
- CRAWFORD, D. L. and GUPTA, R. K., 1990, Oxidation of dibenzothiophene by Cunninghamella elegans. Current Microbiology, 21, 229–231.
- GALLAGHER, C. H., Kocii, J. H. and MANN, D. M., 1965, The effect of phenothiazone on the metabolism of liver mitochondria. Biochemical Pharmacology, 14, 799–811.
- GIEG, L. M., OTTER, A. and FEDORAK, P. M., 1996, Carbazole degradation by Pseudomonas sp. LD2: Metabolic characteristics and the identification of some metabolites. Environmental Science and Technology, 30, 575–585.
- GIRARD, Y., HAMEL, P., THÉRIEN, M., SPRINGER, J. P. and HIRSHFIELD, J., 1987, First synthesis of sulfoxides and sulfones in the 3H-phenothiazin-3-one and 5H-benzo[a]phenothiazin-5 -one ring systems. Addition reactions with nucleophiles. Journal of Organic Chemistry, 52, 4000–4006.
- HALL, T. J., NYUGEN, H., SCHAEUBLIN, M., MICHALSKY, M. and MISSBACH, M., 1996, Phenothiazines are potent inhibitors of osteoclastic bone resorption. General Pharmacology, 27, 845–848.
- KELLY, J. D., WHITLOCK, H. V., PORTER, C. J., GRIFFIN, D. and MARTIN, I. C. A., 1981, Anthelmintic efficacy of low-dose phenothiazine against strains of sheep nematodes susceptible or resistant to thiabendazole, levamisole and morantel tartrate: efficiency against sequentially administered infections. Research in Veterinary Science, 30, 170–174.
- KirrLE, J. D., CALLE, L. M. and SULLIVAN, P. D., 1981, The effect of substituted phenothiazines on the mutagenicity of benzo[a]pyrene. Mutation Research, 80, 259–264.
- KONTIR, D. M., GLANCE, C. A., COLBY, H. D. and MILES, P. R., 1986, Effects of organic solvent vehicles on benzo[a]pyrene metabolism in rabbit lung microsomes. Biochemical Pharmacology, 35, 2569–2575.
- Lum, P. Y., BURKE, M. D., MAYER, R. T. and IOANNIDES, C., 1986, Alkoxyresorufin 0-dealkylases: association with the murine Ah locus. Cancer Letters, 32, 255–262.
- MITCHELL, S. C., 1980, Comparative metabolism of phenothiazine in the rat (Rattus norvegicus), mouse (Mus muscu/us), hamster (Mesocricetus auratus) and gerbil (Gerbillus gerbillus). Comparative Biochemistry and Physiology, 67C, 199–202.
- MITCHELL, S. C., 1982, Mammalian metabolism of orally administered phenothiazine. Drug Metabolism Reviews, 13, 319–343.
- MITCHELL, S. C. and WARING, R. H., 1979, Metabolism of phenothiazine in the guinea pig. Drug Metabolism and Disposition, 7, 399–403.
- MITCHELL, S. C. and WARING, R. H., 1981, A comparison of the in vivo metabolism of phenothiazine and promazine in the neonatal guinea pig. Biology of the Neonate, 39, 285–289.
- PARSHIKOV, I. A., FREEMAN, J. P., WILLIAMS, A. J., MOODY, J. D. and SUTHERLAND, J. B., 1999, Biotransformation of N-acetylphenothiazine by fungi. Applied Microbiology and Biotechnology, 52, 553–557.
- RETTIE, A. E., WILLIAMS, F. M., RAWLINS, M. D., MAYER, R. T. and BURKE, M. D., 1986, Major differences between lung, skin and liver in the microsomal metabolism of homologous series of resorufin and coumarin ethers. Biochemical Pharmacology, 35, 3495–3500.
- ROSEBOOM, H. and PERRIN, J. H., 1977, Oxidation kinetics of phenothiazine and 10-methylphenothiazine in acidic medium. Journal of Pharmaceutical Sciences, 66, 1392–1395.
- SCHLENK, D., BEVER, R. J., VERTINO, A. M. and CERNIGLIA, C. E., 1994, P450 catalysed S-oxidation of dibenzothiophene by Cunninghamella elegans. Xenobiotica, 24, 1077–1083.
- SOMERS, C. J., DOWNEY, N. E. and O'SHEA, J., 1987, Prophylaxis of trichostrongylid infection afforded by low-dose phenothiazine given in two successive years to first-season calves on a common area of pasture. Research in Veterinary Science, 43, 143–149.
- SUTHERLAND, J. B., EVANS, F. E., FREEMAN, J. P., WILLIAMS, A. J., DECK, J. and CERNIGLIA, C. E., 1994a, Identification of metabolites produced from acridine by Cunninghamella elegans. Mycologia, 86, 117–120.
- SUTHERLAND, J. B., FREEMAN, J. P., WILLIAMS, A. J. and CERNIGLIA, C. E., 1994b, N-oxidation of quinoline and isoquinoline by Cunninghamella elegans. Experimental Mycology, 18, 271–274.
- SUTHERLAND, J. B., RAFII, F., KHAN, A. A. and CERNIGLIA, C. E., 1995, Mechanisms of polycyclic aromatic hydrocarbon degradation. In L. Y. Young and C. E. Cerniglia (eds), Microbial Transformation and Degradation of Toxic Organic Chemicals (New York: Wiley-Liss), pp. 269–306.
- TATEISHI, T., NAKURA, H., ASOH, M., WATANABE, M., TANAKA, M., KUMAI, T. and KOBAYASHI, S., 1999, Multiple cytochrome P-450 subfamilies are co-induced with P-glycoprotein by both phenothiazine and 2-acetylaminofluorene in rats. Cancer Letters, 138, 73–79.
- THIMMAIAH, K. N., HORTON, J. K., QIAN, X.-D., BECK, W. T., HOUGHTON, J. A. and HOUGHTON, P. J., 1990, Structural determinants of phenoxazine type compounds required to modulate the accumulation of vinblastine and vincristine in multidrug-resistant cell lines. Cancer Communications, 2, 249–259.
- WADKINS, R. M. and HOUGHTON, P. J., 1993, Kinetics of cellular permeability of phenoxazine and its dependence on P-glycoprotein expression. FEBS Letters, 322, 1–5.
- WANG, R. F., CAO, W. W., KHAN, A. A. and CERNIGLIA, C. E., 2000, Cloning, sequencing, and expression in Escherichia coli of a cytochrome P450 gene from Cunninghamella elegans. FEMS Microbiology Letters, 188, 55–61.
- WARING, R. H. and MITCHELL, S. C., 1985, The metabolism of phenothiazine in the neonatal calf: identification of drug-polypeptide conjugates from urine. Xenobiotica, 15, 459–468.
- ZHANG, D., FREEMAN, J. P., SUTHERLAND, J. B., WALKER, A. E., YANG, Y. and CERNIGLIA, C. E., 1996a, Biotransformation of chlorpromazine and methdilazine by Cunninghamella elegans. Applied and Environmental Microbiology, 62, 798–803.
- ZHANG, D., YANG, Y., LEAKEY, J. E. A. and CERNIGLIA, C. E., 1996b, Phase I and phase II enzymes produced by Cunninghamella elegans for the metabolism of xenobiotics. FEMS Microbiology Letters, 138, 221–226.